中药改善乳腺癌治疗后围绝经期症状的研究综述
乳腺癌手术、放化疗及内分泌治疗提高生存率,但围绝经期症状(血管舒缩、睡眠、关节肌肉症状及骨质疏松)常困扰患者并降低生活质量。目前缺乏满意疗法,中药、针灸、按摩及心理治疗等替代补充疗法日益受期待。本文综述多种中药方剂、活性成分及提取物改善乳腺癌患者围绝经期症状的作用与可能机制,并呼吁设计严谨的标准化临床疗效研究,同时明确含雌激素中药的安全性。
要点
- 乳腺癌治疗后围绝经期症状缺乏满意疗法,中药等替代补充疗法受关注。
- 综述多种中药方剂、活性成分及提取物改善围绝经期症状的作用与机制。
- 需科学设计标准化临床研究评估中药疗效与安全性,尤其含雌激素中药。
核心结论
- 中药方剂、活性成分及提取物在改善乳腺癌治疗后围绝经期症状方面具有潜力和研究价值。
- 需进一步开展科学设计的标准化临床疗效研究以评估中药的疗效与机制。
- 含雌激素中药用于乳腺癌患者的安全性和价值尚需明确。
研究设计与样本
- 本文为综述,检索并汇总多种中药方剂、活性成分或组分、中药提取物及其他草药改善乳腺癌患者围绝经期症状的研究。
- 综述同时阐述上述中药改善围绝经期症状的可能机制。
主要发现
- 乳腺癌手术、放化疗和内分泌治疗成功提高患者生存率,但围绝经期症状作为主要副作用常困扰患者并降低生活质量。
- 围绝经期症状包括血管舒缩症状、睡眠问题、关节肌肉症状和骨质疏松。
- 目前针对这些治疗所致围绝经期症状尚无满意的治疗方法。
- 中药、针灸、按摩和心理治疗等替代补充疗法日益受到期待和探索。
临床怎么用
- 乳腺癌治疗后出现围绝经期症状的患者,可关注中药等替代补充疗法的潜在获益,但需在循证评估基础上使用。
- 使用含雌激素中药时应特别关注乳腺癌患者的安全性,需进一步明确其风险与价值。
局限性
- 综述指出需科学设计并持续开展标准化临床疗效研究,以评估中药的疗效与机制。
- 含雌激素中药用于乳腺癌的安全性和价值尚待阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The application of surgery, chemoradiotherapy, and endocrine treatment successfully increases survival rates of breast cancer patients. However, perimenopausal symptoms, the main side effects of these treatments, often afflict patients and reduce their quality of life. Perimenopausal symptoms include vasomotor symptoms, sleep problems, arthromuscular symptoms, and osteoporosis. Currently, there are no satisfactory treatments for perimenopausal symptoms that result from these treatments. Therefore, alternative and complementary therapies including herbal medicines represented by Chinese medicines (CMs), acupuncture, massage, and psychotherapy are increasingly being expected and explored. In this paper, we review the effects and potentials of several CM formulae, along with some active ingredients or fractions from CMs, Chinese herbal extracts, and other herbal medicines, which have drawn attention for improving perimenopausal symptoms in breast cancer patients. We also elaborate their possible mechanisms. Moreover, further studies for evaluation of standardized clinical efficacy should be scientifically well-designed and continuously performed to investigate the efficacy and mechanisms of CMs for perimenopausal symptoms due to breast cancer therapy. The safety and value of estrogen-containing CMs for breast cancer should also be clarified.
引用
- Wang S, Lin H, Cong W, et al. Chinese Medicines Improve Perimenopausal Symptoms Induced by Surgery, Chemoradiotherapy, or Endocrine Treatment for Breast Cancer. Front Pharmacol. 2019. PMID: 30930771. doi:10.3389/fphar.2019.00174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。